Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1535051/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850113361528750080 |
|---|---|
| author | Fernando Rodríguez-Jorge José Ignacio Fernández-Velasco Noelia Villarrubia Julia Gracia-Gil Eva Fernández Virginia Meca-Lallana Carolina Díaz-Pérez Susana Sainz de la Maza Eva María Pacheco Ana Quiroga Lluis Ramió-Torrentà Sergio Martínez-Yélamos Laura Bau Enric Monreal Ana López-Real Alexander Rodero-Romero Laura Borrega Santiago Díaz Pablo Eguía Mercedes Espiño Juan Luis Chico-García Francisco Javier Barrero María Luisa Martínez-Ginés José Manuel García-Domínguez Soraya De la Fuente Irene Moreno Raquel Sainz-Amo Raquel Sainz-Amo M. Alba Mañé-Martínez Ana Caminero Fernando Castellanos-Pinedo Ana Gómez López Andrés Labiano-Fontcuberta Lucía Ayuso Rossana Abreu Miguel Ángel Hernández José Meca-Lallana Lorena Martín-Aguilar Alfonso Muriel García Jaime Masjuan Lucienne Costa-Frossard Luisa María Villar |
| author_facet | Fernando Rodríguez-Jorge José Ignacio Fernández-Velasco Noelia Villarrubia Julia Gracia-Gil Eva Fernández Virginia Meca-Lallana Carolina Díaz-Pérez Susana Sainz de la Maza Eva María Pacheco Ana Quiroga Lluis Ramió-Torrentà Sergio Martínez-Yélamos Laura Bau Enric Monreal Ana López-Real Alexander Rodero-Romero Laura Borrega Santiago Díaz Pablo Eguía Mercedes Espiño Juan Luis Chico-García Francisco Javier Barrero María Luisa Martínez-Ginés José Manuel García-Domínguez Soraya De la Fuente Irene Moreno Raquel Sainz-Amo Raquel Sainz-Amo M. Alba Mañé-Martínez Ana Caminero Fernando Castellanos-Pinedo Ana Gómez López Andrés Labiano-Fontcuberta Lucía Ayuso Rossana Abreu Miguel Ángel Hernández José Meca-Lallana Lorena Martín-Aguilar Alfonso Muriel García Jaime Masjuan Lucienne Costa-Frossard Luisa María Villar |
| author_sort | Fernando Rodríguez-Jorge |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9cb107f9b61e4287b704f01c96fe1114 |
| institution | OA Journals |
| issn | 1664-3224 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-9cb107f9b61e4287b704f01c96fe11142025-08-20T02:37:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-12-011510.3389/fimmu.2024.15350511535051Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosisFernando Rodríguez-Jorge0José Ignacio Fernández-Velasco1Noelia Villarrubia2Julia Gracia-Gil3Eva Fernández4Virginia Meca-Lallana5Carolina Díaz-Pérez6Susana Sainz de la Maza7Eva María Pacheco8Ana Quiroga9Lluis Ramió-Torrentà10Sergio Martínez-Yélamos11Laura Bau12Enric Monreal13Ana López-Real14Alexander Rodero-Romero15Laura Borrega16Santiago Díaz17Pablo Eguía18Mercedes Espiño19Juan Luis Chico-García20Francisco Javier Barrero21María Luisa Martínez-Ginés22José Manuel García-Domínguez23Soraya De la Fuente24Irene Moreno25Raquel Sainz-Amo26Raquel Sainz-Amo27M. Alba Mañé-Martínez28Ana Caminero29Fernando Castellanos-Pinedo30Ana Gómez López31Andrés Labiano-Fontcuberta32Lucía Ayuso33Rossana Abreu34Miguel Ángel Hernández35José Meca-Lallana36Lorena Martín-Aguilar37Alfonso Muriel García38Jaime Masjuan39Lucienne Costa-Frossard40Luisa María Villar41Neurology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainNeurology Department, Complejo Hospitalario Universitario de Albacete, Albacete, SpainNeurology Department, Complejo Hospitalario Universitario de Albacete, Albacete, SpainNeurology Department, Hospital Universitario La Princesa, Madrid, SpainNeurology Department, Hospital Universitario La Princesa, Madrid, SpainImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainNeurology Department, Hospital Universitario Juan Ramon Jimenez, Huelva, SpainNeurology Department, Hospital Universitario de Gerona Doctor Josep Trueta, Gerona, SpainNeurology Department, Hospital Universitario de Gerona Doctor Josep Trueta, Gerona, SpainNeurology Department, Hospital Universitario de Bellvitge, Barcelona, SpainNeurology Department, Hospital Universitario de Bellvitge, Barcelona, SpainNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainNeurology Department, Complejo Hospitalario Universitario La Coruña, La Coruña, SpainImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainNeurology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain0Neurology Department, Hospital Universitario Gran Canaria Doctor Negrín, Gran Canaria, Spain0Neurology Department, Hospital Universitario Gran Canaria Doctor Negrín, Gran Canaria, SpainImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain1Neurology Department, Hospital Universitario Clínico San Cecilio Granada, Granada, Spain2Neurology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain2Neurology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain3Neurology Department, Hospital Universitario Doce de Octubre, Madrid, Spain4Neurology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, SpainNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain5Neurology Department, Hospital Universitario Joan XXII, Tarragona, Spain6Neurology Department, Complejo Asistencial de Ávila, Ávila, Spain7Neurology Department, Hospital Virgen del Puerto, Cáceres, Spain3Neurology Department, Hospital Universitario Doce de Octubre, Madrid, Spain3Neurology Department, Hospital Universitario Doce de Octubre, Madrid, Spain8Neurology Department, Hospital Universitario Principe de Asturias, Madrid, Spain9Neurology Department, Hospital Universitario Nuestra Señora Candelaria, Tenerife, Spain9Neurology Department, Hospital Universitario Nuestra Señora Candelaria, Tenerife, Spain0Neurology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain1Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain2Biostatistics Department, Hospital Universitario Ramón y Cajal, Madrid, SpainNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, SpainImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spainhttps://www.frontiersin.org/articles/10.3389/fimmu.2024.1535051/fullmultiple sclerosisocrelizumabneurofilament light chainglial fibrillary acidic proteinserum biomarkers |
| spellingShingle | Fernando Rodríguez-Jorge José Ignacio Fernández-Velasco Noelia Villarrubia Julia Gracia-Gil Eva Fernández Virginia Meca-Lallana Carolina Díaz-Pérez Susana Sainz de la Maza Eva María Pacheco Ana Quiroga Lluis Ramió-Torrentà Sergio Martínez-Yélamos Laura Bau Enric Monreal Ana López-Real Alexander Rodero-Romero Laura Borrega Santiago Díaz Pablo Eguía Mercedes Espiño Juan Luis Chico-García Francisco Javier Barrero María Luisa Martínez-Ginés José Manuel García-Domínguez Soraya De la Fuente Irene Moreno Raquel Sainz-Amo Raquel Sainz-Amo M. Alba Mañé-Martínez Ana Caminero Fernando Castellanos-Pinedo Ana Gómez López Andrés Labiano-Fontcuberta Lucía Ayuso Rossana Abreu Miguel Ángel Hernández José Meca-Lallana Lorena Martín-Aguilar Alfonso Muriel García Jaime Masjuan Lucienne Costa-Frossard Luisa María Villar Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis Frontiers in Immunology multiple sclerosis ocrelizumab neurofilament light chain glial fibrillary acidic protein serum biomarkers |
| title | Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis |
| title_full | Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis |
| title_fullStr | Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis |
| title_full_unstemmed | Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis |
| title_short | Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis |
| title_sort | corrigendum biomarkers of response to ocrelizumab in relapsing remitting multiple sclerosis |
| topic | multiple sclerosis ocrelizumab neurofilament light chain glial fibrillary acidic protein serum biomarkers |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1535051/full |
| work_keys_str_mv | AT fernandorodriguezjorge corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT joseignaciofernandezvelasco corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT noeliavillarrubia corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT juliagraciagil corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT evafernandez corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT virginiamecalallana corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT carolinadiazperez corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT susanasainzdelamaza corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT evamariapacheco corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT anaquiroga corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT lluisramiotorrenta corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT sergiomartinezyelamos corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT laurabau corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT enricmonreal corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT analopezreal corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT alexanderroderoromero corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT lauraborrega corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT santiagodiaz corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT pabloeguia corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT mercedesespino corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT juanluischicogarcia corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT franciscojavierbarrero corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT marialuisamartinezgines corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT josemanuelgarciadominguez corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT sorayadelafuente corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT irenemoreno corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT raquelsainzamo corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT raquelsainzamo corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT malbamanemartinez corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT anacaminero corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT fernandocastellanospinedo corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT anagomezlopez corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT andreslabianofontcuberta corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT luciaayuso corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT rossanaabreu corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT miguelangelhernandez corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT josemecalallana corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT lorenamartinaguilar corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT alfonsomurielgarcia corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT jaimemasjuan corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT luciennecostafrossard corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis AT luisamariavillar corrigendumbiomarkersofresponsetoocrelizumabinrelapsingremittingmultiplesclerosis |